二次同胞全合移植治疗幼年型粒单细胞白血病1例

茅君卿; 宋华; 杨世隆; 赵芬英; 沈笛颖; 汤永民

doi:10.7499/j.issn.1008-8830.2013.07.020

PDF(963 KB)

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (7) : 591-593. DOI: 10.7499/j.issn.1008-8830.2013.07.020

病例报告

二次同胞全合移植治疗幼年型粒单细胞白血病1例

茅君卿，宋华，杨世隆，赵芬英，沈笛颖，汤永民

作者信息 +

Second HLA-identical related hematopoietic stem cells transplantation for juvenile myelomonocytic leukemia: one case report

MAO Jun-Qing, SONG Hua, YANG Shi-Long, ZHAO Fen-Ying, SHEN Di-Ying, TANG Yong-Min

Author information +

文章历史 +

摘要

无

Abstract

No abstract available

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

茅君卿，宋华，杨世隆，赵芬英，沈笛颖，汤永民. 二次同胞全合移植治疗幼年型粒单细胞白血病1例[J]. 中国当代儿科杂志. 2013, 15(7): 591-593 https://doi.org/10.7499/j.issn.1008-8830.2013.07.020

MAO Jun-Qing, SONG Hua, YANG Shi-Long, ZHAO Fen-Ying, SHEN Di-Ying, TANG Yong-Min. Second HLA-identical related hematopoietic stem cells transplantation for juvenile myelomonocytic leukemia: one case report[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(7): 591-593 https://doi.org/10.7499/j.issn.1008-8830.2013.07.020

参考文献

［1］Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia［J］. Br J Hematol, 2011, 152(6): 677-687.

［2］Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in the UK: a population-based study of incidence and survival［J］. Br J Haematol, 2003, 121(5): 758-767.

［3］Bresolin S, Zecca M, Flotho C, Trentin L, Zangrando A, Sainati L, et al. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia［J］. J Clin Oncol, 2010, 28(11): 1919-1927.

［4］Mizoguchi Y, Fujita N, Taki T, Hayashi Y, Hamamoto K. Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion［J］. Am J Hematol, 2009, 84(5): 295-297.

［5］Locatelli F, Nolke P, Zecca M, Korthof E, Lanino E, Peters C, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial［J］. Blood, 2005, 105(1): 410-419.

［6］Yoshimi A, Kojima S, Hirano N. Juvenile myelomonocytic leukemia epidemiology, etiopathogenesis, diagnosis, and management considerations［J］. Pediatr Drugs, 2010, 12 (1): 11-21.

［7］Maguire AM, Vowels MR, Russell S, Cohn RJ, Cole C, Saxon B, et al. Allogeneic bone marrow transplant improves outcome for juvenile myelomonocytic leukemia［J］. J Paediatr Child Health, 2002, 38(2): 166-169.

［8］Chang YH, Jou ST, Lin DT, Lu MY, Lin KH. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review［J］. J Pediatr Hematol Oncol, 2004, 26(3): 190-193.

［9］MacMillan ML, Davies SM, Orchard PJ. Haematopoietic cell transplantation in children with juvenile myelomonocytic leukaemia［J］. Br J Haematol, 1998, 103(2): 552-558.

［10］Matthes-Martin S, Mann G, Peters C, Lion T, Fritsch G, Haas OA, et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single centre experience and review of the literature［J］. Bone Marrow Transplant, 2002, 26(4): 377-382.

［11］Bergstraesser E, Hasle H, Rogge T, Fischer A, Zimmermann M, Noellke P, et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria［J］. Pediatr Blood Cancer, 2007, 49(5): 629-633.

［12］Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia［J］. Br J Haematol, 2008, 141(5): 567-575.